首页>
外国专利>
LIVE ATTENUATED INFLUENZA B VIRUS COMPOSITIONS METHODS OF MAKING AND USING THEREOF
LIVE ATTENUATED INFLUENZA B VIRUS COMPOSITIONS METHODS OF MAKING AND USING THEREOF
展开▼
机译:实时减毒的流感B病毒组合物制造和使用方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The NS1 protein of influenza virus is a key virulent element with multi-functional roles in virus replication and acts as a strong interferon (IFN) antagonist. A live attenuated virus (LAIV) is provided using a master backbone, which contains the influenza B (HK8038) virus and includes a deletion of the NSI coding region (DelNS1). The LAIV is based on novel adaptive mutations, which support DelNS1 influenza B live attenuated virus (LAIV) replication in vaccine producing cells. DelNS1 influenza B LAIV shows spontaneous cold adaption with preference to grow at 30-33° C. but restriction at 37-39° C. The LAIV can be used to protect a subject, against a lethal challenge of antigenic distant influenza B viruses. DelNS1 LAIV with adaptive mutations for growing in vaccine producing systems is an important strategy for making highly attenuated and immunogenic live attenuated influenza vaccines with the ability to induce broad cross protective immunity for seasonal influenza.
展开▼